R. Broll

963 total citations
50 papers, 782 citations indexed

About

R. Broll is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, R. Broll has authored 50 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 17 papers in Surgery and 14 papers in Pathology and Forensic Medicine. Recurrent topics in R. Broll's work include Genetic factors in colorectal cancer (14 papers), Colorectal and Anal Carcinomas (8 papers) and Colorectal Cancer Treatments and Studies (8 papers). R. Broll is often cited by papers focused on Genetic factors in colorectal cancer (14 papers), Colorectal and Anal Carcinomas (8 papers) and Colorectal Cancer Treatments and Studies (8 papers). R. Broll collaborates with scholars based in Germany, United States and Sweden. R. Broll's co-authors include M. Duchrow, H.‐P. Bruch, O. Schwandner, Hans‐Peter Bruch, Martin Strik, H. Schimmelpenning, Mirko H. H. Schmidt, U. Windhövel, Thomas Schiedeck and Hans‐Peter Bruch and has published in prestigious journals such as International Journal of Cancer, European Journal of Cancer and The Journal of Pathology.

In The Last Decade

R. Broll

50 papers receiving 752 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
R. Broll 451 276 243 188 147 50 782
David A. Smith 321 0.7× 356 1.3× 160 0.7× 219 1.2× 116 0.8× 26 893
T F Lioe 241 0.5× 258 0.9× 204 0.8× 153 0.8× 228 1.6× 30 797
R von Wasielewski 310 0.7× 241 0.9× 319 1.3× 180 1.0× 261 1.8× 13 789
Younghye Kim 251 0.6× 242 0.9× 247 1.0× 180 1.0× 133 0.9× 30 817
Alessia Caleo 310 0.7× 227 0.8× 271 1.1× 178 0.9× 139 0.9× 38 950
Marco Losa 456 1.0× 107 0.4× 334 1.4× 146 0.8× 242 1.6× 20 812
Alexandros Nomikos 348 0.8× 201 0.7× 232 1.0× 67 0.4× 114 0.8× 29 649
Iwao Seshimo 411 0.9× 120 0.4× 224 0.9× 89 0.5× 120 0.8× 13 631
Ryuichi Denno 276 0.6× 213 0.8× 215 0.9× 47 0.3× 141 1.0× 46 673
Frank Schönleben 505 1.1× 360 1.3× 351 1.4× 77 0.4× 242 1.6× 22 878

Countries citing papers authored by R. Broll

Since Specialization
Citations

This map shows the geographic impact of R. Broll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Broll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Broll more than expected).

Fields of papers citing papers by R. Broll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Broll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Broll. The network helps show where R. Broll may publish in the future.

Co-authorship network of co-authors of R. Broll

This figure shows the co-authorship network connecting the top 25 collaborators of R. Broll. A scholar is included among the top collaborators of R. Broll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Broll. R. Broll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwandner, O., et al.. (2007). Neuroendocrine Differentiation in Primary Rectal Cancer: Immune Histology with Prognostic Impact?. Visceral Medicine. 23(4). 399–407. 1 indexed citations
2.
3.
Duchrow, M., et al.. (2003). Colorectal carcinomas with high MIB‐1 labelling indices but low pKi67 mRNA levels correlate with better prognostic outcome. Histopathology. 42(6). 566–574. 27 indexed citations
4.
Schmidt, Mirko H. H., R. Broll, Hans‐Peter Bruch, & M. Duchrow. (2002). Proliferation marker pKi‐67 affects the cell cycle in a self‐regulated manner. Journal of Cellular Biochemistry. 87(3). 334–341. 17 indexed citations
5.
Schmidt, Mirko H. H., R. Broll, Hans‐Peter Bruch, Oliver Bögler, & M. Duchrow. (2002). The proliferation marker pKi‐67 organizes the nucleolus during the cell cycle depending on Ran and cyclin B. The Journal of Pathology. 199(1). 18–27. 32 indexed citations
6.
Broll, R., et al.. (2002). The proliferation marker pKi-67 becomes masked to MIB-1 staining after expression of its tandem repeats. Histochemistry and Cell Biology. 118(5). 415–422. 8 indexed citations
7.
Duchrow, M., Mirko H. H. Schmidt, R. Broll, et al.. (2002). VEGF isoforms and mutations in human colorectal cancer. International Journal of Cancer. 101(1). 32–36. 37 indexed citations
8.
Duchrow, M., et al.. (2001). Assessment of Proliferative Activity in Colorectal Carcinomas by Quantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR). Cancer Investigation. 19(6). 588–596. 6 indexed citations
9.
Duchrow, M., et al.. (2001). Suppression of Cell Division by pKi-67 Antisense-RNA and Recombinant Protein. Cellular Physiology and Biochemistry. 11(6). 331–338. 18 indexed citations
10.
Broll, R., Michael Weschta, Sarah Berndt, et al.. (2001). Prognostic significance of free gastrointestinal tumor cells in peritoneal lavage detected by immunocytochemistry and polymerase chain reaction. Langenbeck s Archives of Surgery. 386(4). 285–292. 23 indexed citations
11.
Schwandner, O., H.‐P. Bruch, & R. Broll. (2001). p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance?. International Journal of Colorectal Disease. 17(1). 11–19. 37 indexed citations
12.
Schimmelpenning, H., Jens K. Habermann, Stefan Krüger, et al.. (2000). Das Colitis ulcerosa-assoziierte kolorektale Karzinom - DNS-Ploidie als Indikator einer drohenden malignen Transformation? -. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 125(Heft 11). 880–887. 1 indexed citations
13.
Schwandner, O., et al.. (2000). p53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer. European Journal of Cancer. 36(3). 348–356. 51 indexed citations
14.
Broll, R., A A Stark, U. Windhövel, et al.. (1999). Expression of p53 and mdm2 mRNA and protein in colorectal carcinomas. European Journal of Cancer. 35(7). 1083–1088. 15 indexed citations
15.
Broll, R., et al.. (1998). Assessment of the proliferation index in gastric carcinomas with the monoclonal antibody MIB 1. Journal of Cancer Research and Clinical Oncology. 124(1). 49–54. 13 indexed citations
16.
Broll, R., Christian Eckmann, P. Kujath, & H.‐P. Bruch. (1998). „Streptococcal toxic shock-like syndrome“. Der Chirurg. 69(8). 806–812. 4 indexed citations
17.
Broll, R., H. Schimmelpenning, Martin Strik, et al.. (1997). Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas. Diseases of the Colon & Rectum. 40(12). 1465–1471. 105 indexed citations
18.
Broll, R., M. Duchrow, H. Schimmelpenning, et al.. (1996). Tumorzelldissemination in das Knochenmark und in die Peritonealhohle eine immunzytochemische Untersuchung an Patienten mit einem Magen- oder kolorektalen Karzinom. Langenbeck s Archives of Surgery. 381(1). 51–8. 32 indexed citations
19.
Kujath, P., Christian Eckmann, R. Broll, Alexander Woltmann, & G. Hohlbach. (1995). Das magenstumpfkarzinom: Diagnose, operatives vorgehen und prognose. Langenbeck s Archives of Surgery. 380(2). 3 indexed citations
20.
Broll, R., et al.. (1986). Replacement of Dog’s Aorta by Autologous Intestinal Muscle in the Infected Retroperitoneum. European Surgical Research. 18(6). 390–396. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026